Cortical volume and folding abnormalities in Parkinson's disease patients with pathological gambling

Parkinsonism and Related Disorders

Volumn 20, Issue 11, 2014, Pages 1209-1214

  Cerasa, Antonio ^a   Salsone, Maria ^a,b   Nigro, Salvatore ^a   Chiriaco, Carmelina ^a   Donzuso, Giulia ^a   Bosco, Domenico ^c   Vasta, Roberta ^a   Quattrone, Aldo ^a,b  

^a INSTITUTE OF MOLECULAR BIOIMAGING AND PHYSIOLOGY   (Italy)

^b UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^c SAN GIOVANNI DI DIO HOSPITAL   (Italy)

Author keywords

Cortical folding; Orbitofrontal cortex; Parkinson's disease; Pathological gambling; Voxel based morphometry

Indexed keywords

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN SIZE; CINGULATE GYRUS; CLINICAL ARTICLE; COMPULSION; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; FRONTAL CORTEX; GRAY MATTER; GREY MATTER ATROPHY; HUMAN; IMPULSIVENESS; INFERIOR FRONTAL CORTEX; INSULA; MALE; NERVE DEGENERATION; NEUROANATOMY; ORBITAL CORTEX; PARKINSON DISEASE; PATHOLOGICAL GAMBLING; VOXEL BASED MORPHOMETRY; AGED; ANALYSIS OF VARIANCE; BRAIN CORTEX; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; COMPLICATION; ETIOLOGY; GAMBLING; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PSYCHOLOGICAL RATING SCALE; THREE DIMENSIONAL IMAGING;

AGED; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; CEREBRAL CORTEX; CHI-SQUARE DISTRIBUTION; FEMALE; GAMBLING; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PSYCHIATRIC STATUS RATING SCALES;

EID: 84908591731     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2014.09.001     Document Type: Article

References (32)

1. Djamshidian A., Cardoso F., Grosset D., Bowden-Jones H., Lees A.J. Pathological gambling in Parkinson's disease - a review of the literature. Mov Disord 2011, 26:1976-1984.
2. Weintraub D., Koester J., Potenza M.N., Siderowf A.D., Stacy M., Voon V. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 2010, 67:589-595.
3. Santangelo G., Barone P., Trojano L., Vitale C. Pathological gambling in Parkinson's disease. A comprehensive review. Park Relat Disord 2013, 19:645-653.
4. Frosini D., Pesaresi I., Cosottini M., Belmonte G., Rossi C., Dell'Osso L., et al. Parkinson's disease and pathological gambling: results from a functional MRI study. Mov Disord 2010, 25:2449-2453.
5. Steeves T.D.L., Miyasaki J., Zurowski M., Lang A.E., Pellecchia G., Van Eimeren T. Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study. Brain 2009, 132:1376-1385.
6. Ashburner J. Afast diffeomorphic image registration algorithm. Neuroimage 2007, 38:95-113.
7. Schaer M., Cuadra M.B., Tamarit L., Lazeyras F., Eliez S., Thiran J.P. Asurface-based approach to quantify local cortical gyrification. IEEE Trans Med Imaging 2008, 27:161-170.
8. Hughes A.J., Daniel S.E., Kilford L., Lees A.J. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. JNeurol Neurosurg Psychiatry 1992, 55:181-184.
9. Tomlinson C.L., Stowe R., Patel S., Rick C., Gray R., Clarke C.E. Systematic review of levodopa equivalency reporting in Parkinson's disease. Mov Disord 2010, 25:2649-2653.
10. Kim S.W., Grant J.E., Potenza M.N., Blanco C., Hollander E. The gambling symptom assessment scale (G-SAS): a reliability and validity study. Psychiatry Res 2009, 166:76-84.
11. Patton J.H., Stanford M.S., Barratt E.S. Factor structure of the Barratt impulsiveness scale. JClin Psychol 1995, 51:768-774.
12. Fischl B., Dale A.M. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci U S A 2000, 97:11050-11055.
13. Cerasa A., Quattrone A., Piras F., Mangone G., Magariello A., Fagioli S., et al. 5-HTTLPR, anxiety, and gender interaction moderates right amygdala volume in healthy subjects. Soc Cogn Affect Neurosci 2013, 10.1093/scan/nst144.
14. Zilles K., Armstrong E., Schleicher A., Kretschmann H.J. The human pattern of gyrification in the cerebral cortex. Anat Embryol 1988, 179:173-179.
15. Choi J.S., Shin Y.C., Jung W.H., Jang J.H., Kang D.H., Choi C.H. Altered brain activity during reward anticipation in pathological gambling and obsessive-compulsive disorder. PloS One 2012, 7:e45938.
16. Rossi M., Gerschcovich E.R., de Achaval D., Perez-Lloret S., Cerquetti D., Cammarota A. Decision-making in Parkinson's disease patients with and without pathological gambling. Eur J Neurol 2010, 17:97-102.
17. Voon V., Pessiglione M., Brezing C., Gallea C., Fernandez H.H., Dolan R.J., et al. Mechanisms underlying dopamine-mediated reward bias in compulsive behaviors. Neuron 2010, 65:135-142.
18. Kapellou O., Counsell S.J., Kennea N., Dyet L., Saeed N., Stark J., et al. Abnormal cortical development after premature birth shown by altered allometric scaling of brain growth. PLoS Med 2006, 3:e26.
19. Mangin J.F., Jouvent E., Cachia A. In-vivo measurement of cortical morphology: means and meanings. Curr Opin Neurol 2010, 23:359-367.
20. Feess-Higgins A., Larroche J.G. Development the human foetal brain. An anatomical atlas 1987, Masson, Paris.
21. White T., Su S., Schmidt M., Kao C.Y., Sapiro G. The development 01 gyrification in childhood and adolescence. Brain Cogn 2010, 72:36-45.
22. Palaniyappan L., Marques T.R., Taylor H., Handley R., Mondelli V., Bonaccorso S. Cortical folding defects as markers of poor treatment response in first-episode psychosis. JAMA Psychiatry 2013, 70:1031-1040.
23. Bastiaens J., Dorfman B.J., Christos P.J., Nirenberg M.J. Prospective cohort study of impulse control disorders in Parkinson's disease. Mov Disord 2013, 28:327-333.
24. Ceravolo R., Frosini D., Rossi C., Bonuccelli U. Impulse control disorders in Parkinson's disease: definition, epidemiology, risk factors, neurobiology and management. Park Relat Disord 2009, 15(Suppl.4):S111-S115.
25. van Eimeren T., Ballanger B., Pellecchia G., Miyasaki J.M., Lang A.E., Strafella A.P. Dopamine agonists diminish value sensitivity of the orbitofrontal cortex: a trigger for pathological gambling in Parkinson's disease?. Neuropsychopharmacology 2009, 34:2758-2766.
26. Voon V., Gao J., Brezing C., Symmonds M., Ekanayake V., Fernandez H., et al. Dopamine agonists and risk: impulse control disorders in Parkinson's disease. Brain 2011, 134:1438-1446.
27. Compton R.J. The interface between emotion and attention: a review of evidence from psychology and neuroscience. Behav Cogn Neurosci Rev 2003, 2:115-129.
28. Kwon J.S., Lee D.W., Lee J.S., Lee D.S., Kim M.S. Neural correlates of clinical symptoms and cognitive dysfunctions in obsessive-compulsive disorder. Psychiatry Res 2003, 122:37-47.
29. Volkow N.D., Fowler J.S., Wang G.J. The addicted human brain viewed in the light of imaging studies: brain circuits and treatment strategies. Neuropharmacology 2004, 47(Suppl.1):3-13.
30. Cilia R., Siri C., Marotta G., Isaias I.U., De Gaspari D., Canesi M. Functional abnormalities underlying pathological gambling in Parkinson's disease. Arch Neurol 2008, 65:1604-1611.
31. Ishihara L., Brayne C. What is the evidence for a premorbid parkinsonian personality: a systematic review. Mov Disord 2006, 21:1066-1072.
32. Ibarretxe-Bilbao N., Tolosa E., Marti M.J., Valldeoriola F., Bargallo N. Neuroanatomical correlates of impaired decision-making and facial emotion recognition in early Parkinson's disease. Eur J Neurosci 2009, 30:1162-1171.